Nanotechnology could help with prostate cancer treatment options
the ONA take:
Novel nanotechnology could help men with prostate cancer make better decisions in treatment options, a study published in PLUS One suggested.
Researchers from Northwestern University led by Vadim Backman, PhD, used an optical technique he pioneered called partical wave spectroscopic (PWS) microscopy. The technology is able to detect cell features as precise as 20 nanometers which would help to distinguish cells that would appear normal with standard microscopy techniques.
The researchers analyzed prostate tissue biopsies from two cohorts of men with prostate cancer. They found a dramatic increase in nano-architectural disorder in progressors as compared to non-progressors.
As the first study to use PWS microscopy to predict cancer prognosis, the authors stated that the technology could be effective in avoiding unnecessary aggressive treatment in men with prostate cancer, which could lead to adverse events.
Novel nanotechnology could help men with prostate cancer make better decisions in treatment options.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|